18H.F · PreveCeutical Medical Inc

-

Please sign in to comment on 18H.F

1 Comment

Admin

3 years, 7 months ago

PreveCeutical Medical Inc is currently in a long term downtrend where the price is trading 45.6% below its 200 day moving average.

From a valuation standpoint, the stock is 50.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1973.4.

PreveCeutical Medical Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 173.8% to $451K since the same quarter in the previous year.

Finally, its free cash flow grew by 1013.7% to $499K since the same quarter in the previous year.

Based on the above factors, PreveCeutical Medical Inc gets an overall score of 2/5.

ISIN	CA74141E1043
CurrencyCode	EUR
Exchange	F
Industry	Biotechnology
Sector	Healthcare

Beta	1.03
Market Cap	9M
Target Price	None
PE Ratio	None
Dividend Yield	0.0%

ABOUT

PreveCeutical Medical Inc

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

18H.F · PreveCeutical Medical Inc

-

PreveCeutical Medical Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest PreveCeutical Medical Inc using a moving average strategy